TCRαβ+/CD19+ depleted Haploidentical HSCT
TCR-αβ+ and CD19+ Depleted KIR/KIR Ligand-mismatched Haploidentical Hematopoietic Stem Cell Transplant and Zoledronate for Pediatric Relapsed/Refractory Hematologic Malignancies and High Risk Solid Tumors
More Information
- Trial Status
- Accepting patients
- Trial Phase
- Phase 1
- Enrollment
- 22 patients (estimated)
- Sponsors
- University of Wisconsin Health
- Tags
- T Cell, Chemotherapy, Allogeneic Stem Cell Transplant, Adoptive Cellular Therapy, CD19
- Trial Type
- Treatment
- Last Update
- SparkCures ID
- 1660
- NCT Identifier
- NCT02508038
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.